Compare Cisco Systems Inc (CSCO) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cisco Systems Inc vs Revvity Inc — how do they compare? Cisco Systems Inc trades at $118.39 (market cap $452.96B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: Cisco Systems Inc is far larger — about 26.7× Revvity Inc's market cap, and Cisco Systems Inc pays the higher dividend (1.46%). Which is the better fit depends on your goals — on Pluang, investors hold Cisco Systems Inc for 86 Days and Revvity Inc for 12 Days on average.
| CSCO | RVTY | |
|---|---|---|
Market Cap | $452.96B | $16.98B |
Volume | 12,951,578 | 1,456,900 |
Sector | Technology | Health |
52-Week High | $130.00 | $157.36 |
52-Week Low | $67.46 | $82.26 |
Typical Hold Time | 86 Days | 12 Days |
Enterprise Value | $466.58B | $19.30B |
Dividend Yield | 1.46% | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cisco Systems (CSCO) trades at $114.89, down 2.13% on the day, amid a bullish technical outlook supported by moving averages and strong institutional sentiment. The company reported robust Q2 2026 EPS of $1.22, beating estimates, with revenue growth driven by AI networking demand. Analysts maintain a 51.35% buy rating with a $129.77 consensus target, highlighting multi-year growth potential from AI infrastructure and Splunk integration.
The stock presents a favorable risk-reward profile with solid fundamentals, including a 20.95% net margin and consistent earnings beats. Key risks include competitive pressures in AI security and cyclical IT spending. Upside is supported by strong cash flow and strategic partnerships, though valuation multiples like a 34.5 P/E warrant monitoring amid macroeconomic uncertainties.
RVTY trades at $152.16, down 0.94% today, near its recent 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Recent positive developments include a Zacks upgrade to Buy (2026-10-02) and the launch of a new Type 1 diabetes screening kit in Europe (Business Wire, 2026-09-24).
The outlook is positive, supported by earnings momentum and strategic expansions, but the stock's premium valuation (P/E of 73.15) and margin pressures pose risks. Analyst consensus is bullish with a $132.13 price target, though the current price exceeds it, suggesting near-term consolidation may occur before further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cisco Systems Inc
Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
